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Tuesday, March 3, 2009 445ametals to an LNR via isothermal titration calorimetry (ITC). In this work, we
used a combination of computer modeling and experimental approaches to
characterize and compare the Ca2þ binding affinities and coordination geome-
tries of various LNR sequences from different proteins. We expect this work to
elucidate the basis for Ca2þ ion selectivity by the LNRs that is integral for their
structural integrity and is required for the proper regulation of the Notch signal-
ing pathway.
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Previous research has led to the discovery that the plasma membrane signaling
protein PLCb1 is sometimes present in the nucleus. Little is known how PLCb1
is regulated in the nucleus on the plasma membrane. PLCb1 activity is regu-
lated by G proteins but these have not been found in the nucleus. The focus
of this study is to find binding partners for nuclear PLCb1 and investigate their
role in the regulation of its activity in the nucleus. A protein called translin-as-
sociated factor-X, TRAX, has been identified as a potential binding partner for
nuclear PLCb1. The work done in this report shows that the two proteins bind
in vitro and in living cells. Using a combination of biophysical and biochemical
methods, we find the two proteins interact and that TRAXmay regulate nuclear
PLCb1 activity.
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The human pregnane X receptor (PXR) is a transcriptional regulator of many
genes involved in xenobiotic metabolism and excretion. Human PXR activators
include an extensive range of structurally diverse endogenous molecules, drugs
which potentially result in potential drug-drug interactions. Reliable prediction
ofmolecules interactingwith this receptor would be valuable for pharmaceutical
drug discovery and environmental applications. In the current study, computa-
tionalmodels for humanPXRactivators andPXRnon-activatorswere developed
using support vector machine (SVM) algorithms using Shape Signatures and
MOEdescriptors. Themodelswere validated using separate test sets. The overall
test set prediction accuracy for PXR activators with SVMwas 72 to 81 % in line
with a previous study usingVolSurf descriptors and SVM.We have also used the
rigorous docking program GOLD and coupled the GoldScore with other scoring
functions in an attempt to improve docking results from those previously at-
tained. In this study, the best docking prediction accuracy (61 %) was obtained
using 1D Shape Signature descriptors as a weighting factor to the GoldScore.
We have also combined the available human PXR data sets into a single larger
model (~300 molecules) and described the specific molecular descriptors that
we demonstrate can help predict whether a molecule activates PXR. These com-
bined computational approaches could enable us to more confidently identify
PXR activators and to further avoid them in various applications.
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Upon substrate binding the isolated plasma membrane H(þ)-ATPase (Pma1)
from Kluyveromyces lactis displays large changes in fluorescence intensity
(Sampedro et al, 2007 Biochemistry 46:5616-5622). The nucleotide binding
domain (N-domain) contains one Trp505 residue, that seems to be responsible
for the variations in intrinsic fluorescence. The N-domain was cloned and the
protein expressed in E. coli. The purified N-domain displayed nucleotide-de-
pendent (ATP and ADP) quenching of fluorescence similar to that observed
in the whole Pma1. The dissociation constants (Kd) for ATP and ADP were
100 and 110 uM respectively. Fluorescence resonance energy transfer
(FRET) studies were also performed by using mantATP; a fluorescent ATP an-
alog (Ex. 337 nm, Em. 423nm). The absorbance spectra of mantATP overlaps
the fluorescence spectra of the N-domain, and thus FRET was observed by
exciting at 280 nm. FRET efficiency was 100% indicating a close proximity
between Trp505 and the nucleotide. Therefore, in this domain there is a Trpresidue located near the substrate binding site which is of high value to deter-
mine Kds and molecular distances using fluorescence.
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Long QT syndrome (LQTS) is a cardiac muscle abnormality caused either by
congenital or drug-induced malfunctioning of potassium channels localized in
the myocardium cell membranes. LQTS can lead to ventricular arrhythmia and
sudden cardiac death. A number of prescription medications inducing long QT
have been withdrawn from the market over the past decades, and virtually all
cases of drug-induced LQTS are due to the blockade of the heart human
ether-a-go-go-related-gene (hERG) potassium channel. Evidences show that
most of the hERG-channel blockers would exert their activity by binding one
or several sites located in the pore region composed of the last two TM helices
(S5 and S6) or on the extracellular region connecting S5 and S6 together. In this
work, we studied the binding of 4 cardiotoxic drugs (bepridil, cetirizine, di-
phenhydramine, pentamidine) with a portion of the extracellular segment
(Ile583 - Tyr597) of the hERG channel and a model membrane. Drug-peptide in-
teractions were studied using 1H liquid-state NMR with pulsed field gradient
self-diffusion measurements. According to our CD and 1H NMR results, the
peptide appears to be unstructured both in water and membrane mimetic isotro-
pic bicelles. Diffusion measurements suggest that there is no or only weak drug
binding to the peptide. However, a strong interaction with the model membrane
was evidenced for the bepridil molecule, thus suggesting a potential role of the
membrane in the cardiotoxicity of LQTS-active drugs. Our current work, which
focuses on drug-membrane interactions and hERG peptide-membrane interac-
tions by 31P and 2H solid-state NMR will also be presented.
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Toxic metals are known to displace physiologically-relevant metal ions in pro-
teins, and may activate or deactivate protein function in response to changes in
the free metal concentration. To investigate potential relationships between
metal/protein complexes and toxicity, an analysis of proteins structural and
sequential data was used to establish statistical bases for identifying key selec-
tivity factors associated with Pb2þ-protein binding. These data led us to hypoth-
esize that Pb2þ, and potentially other toxic metals, may induce opportunistic
binding in regions of negative electrostatic potential, thus altering the proteins
conformation.
To compare structural/conformational changes, investigate selectivity and
affinity, and probe the mechanism of toxic metal-protein interactions, several
natural and engineered Ca2þ-binding proteins (CaBPs) were analyzed using
Fluorescence, CD and 1D and 2D NMR spectroscopy. Engineered proteins
were developed based on grafting methods that involved insertion of metal-
binding motifs in flexible regions of protein scaffolds to investigate biophysical
properties associated with binding reactions in isolated sites. Additionally, the
ubiquitous signaling protein calmodulin (CaM) was evaluated extensively to
determine changes associated with competitive binding between Ca2þ and
anthropogenically available toxicants such as Pb2þ, Gd3þ, La3þ, Tb3þ and
In3þ. Results suggest that certain toxic metals may not only displace the biolog-
ically-relevant metals in metalloproteins, but support our hypothesis that op-
portunistic binding occurs in non-sites. This has important implications for
the potential binding of toxic metals by non-metalloproteins, as well as provid-
ing a basis for understanding the impact of toxicity related to downstream
protein-protein interactions.
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The chloride/proton transporter ClC-5 mediates the re-absorption of filtered
proteins in the kidney by promoting the formation of the macromolecular en-
docytic complex and by aiding in endosomal acidification upon complex
internalization in proximal tubule cells. Mutations disrupting ClC-5 lead to
proteinuria reflecting a severe impairment of renal receptor endocytosis and
446a Tuesday, March 3, 2009several disease-causing mutations in ClC-5 translate into truncations of the
carboxy terminus (Ct), highlighting the significance of this region. The Ct in-
teracts with the scaffold protein NHERF2 (Naþ/Hþ exchanger regulatory fac-
tor 2) and leads to enhanced endocytic uptake of albumin by kidney cells
[Hryciw, D. et al. 2006]. This interaction occurs through the second PDZ do-
main of NHERF2 and an unknown binding site on the Ct of ClC-5 [Hryciw,
D. et al. 2006]. In the present study NHERF2/ClC-5 Ct interactions were con-
firmed and a putative internal PDZ binding motif TSII (residues 657-60) was
identified in the Ct. Mapping of this motif on the crystal structure of ClC-5
reveals it lies up-stream of a b-turn, a secondary structure element thought
to be critical for PDZ domain recognition of an internal motif [Hillier, B.
et al. 1999]. The strategic S658A mutation completely abolishes NHERF2
binding in vitro suggesting the PDZ binding motif was targeted. CD analysis
confirmed similar spectra between wildtype and S658A mutant, indicating
that this mutation does not lead to gross misfolding of the Ct. The disease mu-
tant R648X which removes this critical S658 abolishes NHERF2 interactions
providing further evidence the internal PDZ binding motif was targeted. Fu-
ture work will focus on identifying proteins interacting with the ClC-5/
NHERF2 complex and deciphering the role of this complex in renal endocy-
tosis. This work was supported by the Kidney Foundation of Canada operating
gant to C.B. and a NSERC studentship to L.W.
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Fibroblast Growth Factors (FGFs) belong to a large family of b-trefoil poly-
peptide growth factors and contain no disulfide binds. FGFs are involved in
various important biological processes such as development and maintenance
of cells. FGFs are about 154 amino acids long and are believed to share
a common core of 140 amino acids with 6 invariant proline residues. The
secondary structural elements in FGFs include 12 antiparallel beta-sheets ar-
ranged in to a beta-barrel motif. Critical analyses of the three-dimensional
structure of human acidic fibroblast factpr (hFGF-1) show that proline resi-
dues play a critical role in shaping the beta-barrel architecture of the protein.
In this context, using a site-directed mutagenesis approach, we examined the
effects of substitution of proline on the structure, stability and function of
hFGF-1. The stability of of the various proline mutants of FGF-1, were as-
sessed by differential scanning calorimetry, limited proteolytic digestion,
and urea-induced equilibrium unfolding. Conformational changes induced
in the various proline mutants of hFGF-1 have been studied using 1-ani-
lino-8-napthalene sulfonate binding, far UV circular dichroism, and multidi-
mensional NMR spectroscopy. The heparin and receptor binding affinities of
the hFGF-1 mutants were investigated by isothermal titration calorimetry.
The results of this study are expected to provide valuable information for a ra-
tional design of hFGF-1 with increased stability and enhanced cell prolifer-
ation activity.
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HIV-1 reverse transcriptase is a complex multi-subunit enzyme that converts
single stranded viral RNA into double stranded proviral DNA. This enzyme
possesses both DNA polymerase and RNase H activity. Structurally, RT is
composed of a 66 kD (p66) subunit and a 51 kD (p51) subunit that lacks an RN-
ase H domain. The homodimers retain DNA polymerase activity but only the
p66/p66 homodimer has RNase H activity. In solution, the enzyme exists as
an equilibrium mixture of the heterodimer p66/p51, two homodimers p66/
p66 and p51/p51 and the two monomers. The nonnucleoside reversible inhib-
itor (NNRTI) efavirenz enhances dimerization of p66/p51, p66/p66, and p51/
p51. The drug binds both monomeric and dimeric RTs. However, structural
changes induced by drug binding are unknown. A combination of hydrogen
deuterium exchange and mass spectrometry is used to probe the solution struc-
ture of RT monomers in the presence and absence of efavirenz. Here we dem-
onstrate that p66 and p51 monomers have similar solution structures, which
resemble the p51 subunit in the crystal structure of p66/p51 heterodimer. After
drug binding the solution structure of the monomers changes to resemble the
p66 subunit in the crystal structure of the heterodimer. We also show that res-
idues in the drug binding pocket of p66/p51-efavirenz complex are affected by
drug binding to monomer.2302-Pos Board B272
Stabilizing Interactions In TNF Ligand-receptor Binding
Christopher Valley, Jonathan Sachs.
University of Minnesota, Minneapolis, MN, USA.
High-affinity binding of extracellular protein ligands belonging to the tumor
necrosis factor (TNF) superfamily to their conjugate transmembrane cell sur-
face TNF receptors initiates the extrinsic signaling cascade that results in apo-
ptotic cell death. Intriguingly, despite a high-degree of structural homology
among the family of ligands and receptors, the ligand binding is both high-af-
finity and has high-specificity. As yet, it is poorly understood what confers this
specificity. Starting from the crystal structures for the TRAIL-death receptor 5
and LTa-TNF receptor 1 complexes, we used all-atom molecular dynamics
simulations to investigate the stabilizing interactions between these ligand-re-
ceptor pairs. Additionally, we simulated both complexes with destabilizing
point mutations. The simulation results yield insight into published experimen-
tal data as well as the underlying mechanism of high affinity ligand-receptor
binding.
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Fibroblast growth factors (FGFs) are heparin binding proteins that help regulate
key cellular processes such as wound healing and differentiation, cell prolifer-
ation, cell migration, morphogenesis, and angiogenesis. The FGF signaling is
generated by the binding of the ligand (FGF) to the extracellular domain of
the FGFR, this binding induces dimerization of FGFR, which is an essential
step in FGF signaling. Fibroblast growth factor receptor (FGFR) extracellular
domain consists of three Ig domains D1, D2, and D3. Between the Domains
D1 and D2 is a short span of acidic residues called the ‘‘acid box’’. The D1-
D2 linker is thought to play a role in regulation of FGF interaction with
FGFR. Many of the FGF binding sites can be found on the extracellular D2 do-
main of the receptor. It is believed that ‘‘acid box’’ can regulate FGF binding to
FGFR. The ‘‘acid box’’ can mimic heparin like compounds and bind at the hep-
arin binding sites located on the surface of the D2 region of FGFR. In the pres-
ent study, we synthesized a twenty-eight amino acid box region peptide and
studied its interaction with D2 domain of FGFR using various biophysical tech-
niques including multidimensional NMR spectroscopy. Equilibrium unfolding
experiment monitored steady state fluorescence, far-UV circular dichrosim and
proteolytic digestion experiments reveal that acid box binds to D2 domain very
weakly. Two-dimensional nuclear magnetic resonance 1H-15N HSQC experi-
ments show that the acid box binds to the FGF-1 and heparin binding sites in
the N-terminal end of the D2 domain of FGFR. Our results clearly show that
the acid box peptide binds to the ligand binding domain of the fibroblast growth
factor receptor.
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S100A13 is a calcium binding chaperone protein, known to be involved in the
non-classical export of signal peptide less proteins such as fibroblast growth
factor (FGF-1) and interleukin-1a across the cell membrane. It has also been
shown that the interaction of S100A13 with Annexin II, which exhibits an in-
ducible flip-flop mechanism across the cell bilayer, helps the multiprotein re-
lease complex to traverse the membrane bilayer. The interaction of S100A13
and annexin II has been characterized using various biophysical techniques
including multidimensional NMR spectroscopy. Results of the Isothermal titra-
tion calorimetry (ITC) experiments show that holo-S100A13 exhibits preferen-
tial binding to annexin II with high affinity in the micro molar rang compared to
apo-S100A13. Equilibrium guanidine hydrochloride denaturation monitored by
steady-state fluorescence and limited trypsin digestion analysis reveals holo-
S100A13 is significantly stabilized upon binding to annexin II peptide
compared to apo-S100A13. ANS (8-anilino-1-napthalene sulfonate) binding
experiments indicates that the presence of annexin II peptide does not increase
the solvent availability of hydrophobic residues in holo-S100A13. Availability
of the solvent-exposed hydrophobic surface(s) in apoS10013 does not facilitate
its interaction with the annexin II peptide, which is unique characteristic of
S100A13. 1H-15N- HSQC NMR experiments reveal that the binding site of an-
nexin II peptide on holo-S100A13 is modestly different from other S100/An-
nexin interactions. S100 proteins typically interact with more than one Annexin
protein. In order to define the specificity of S100A13 for Annexin 2, the inter-
action of S100A13 with other Annexin peptides was characterized and data
